|
Volumn 92, Issue 21, 1995, Pages 9560-9564
|
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
a,c a a a a b b a a,d |
Author keywords
diabetes mellitus; islets of Langerhans; tolerance; transplantation
|
Indexed keywords
BLOCKING ANTIBODY;
CD40 ANTIGEN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD40;
STREPTOZOCIN;
UNCLASSIFIED DRUG;
ALLOGRAFT;
ALLOTRANSPLANTATION;
ANIMAL CELL;
ANIMAL MODEL;
ANTIGEN SPECIFICITY;
ARTICLE;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
DIABETES MELLITUS;
GRAFT REJECTION;
GRAFT SURVIVAL;
IMMUNOLOGICAL TOLERANCE;
INTRAPERITONEAL DRUG ADMINISTRATION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MOUSE;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
SPLEEN CELL;
STREPTOZOCIN DIABETES;
T LYMPHOCYTE ACTIVATION;
ANIMAL;
ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE;
CD40 LIGAND;
CROSSES, GENETIC;
DIABETES MELLITUS, EXPERIMENTAL;
GRAFT SURVIVAL;
ISLETS OF LANGERHANS TRANSPLANTATION;
LYMPHOCYTE TRANSFUSION;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C3H;
MICE, INBRED C57BL;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TRANSPLANTATION, HOMOLOGOUS;
ANIMALIA;
|
EID: 0028882526
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.92.21.9560 Document Type: Article |
Times cited : (383)
|
References (46)
|